Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Oculis Holding AG - Ordinary shares
(NQ:
OCS
)
27.72
+0.15 (+0.54%)
Streaming Delayed Price
Updated: 4:00 PM EST, Mar 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Oculis Holding AG - Ordinary shares
< Previous
1
2
3
Next >
Harley-Davidson, Sportsman's Warehouse And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
April 13, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Oculis to Participate at Upcoming Investor Conferences
April 05, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis to Host Conference Call on April 13, 2023 to Discuss Late-Stage Pipeline and Near-Term Clinical Milestones
April 04, 2023
From
Oculis SA
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
↗
March 27, 2023
On Monday, 89 stocks made new 52-week lows.
Via
Benzinga
Oculis to Ring Nasdaq Stock Market Opening Bell in Celebration of its Successful Listing
March 22, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis Completes Enrollment in Phase 3 OCS-01 OPTIMIZE Trial
March 16, 2023
From
Oculis SA
Via
GlobeNewswire
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
March 06, 2023
Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch...
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.